Tóth Ágnes

University of Debrecen Faculty of Health Sciences

Institute of Health Studies

Integratív Egészségtudományi Tanszék

2020-

Publication list

Tudóstér co-authors statistics filterable publication list

Export to RIS (EndNote, Mendeley, RefWorks, Zotero etc.)

Upload publications

Request certified publication list

Uploaded publications:

Publications in DEA:

OA:

Date range:

2009-2025

2025

Ghanem, A. S., Faludi, E., Bata, R., Mezei, E., Hadar, V., Móré, M., Tóth, Á., Nagy, A. C.: Cancer prevalence and its determinants in Hungary: analyzing data from the 2009, 2014, and 2019 European Health Interview Surveys.
PLoS One. 20 (2), 1-19, (article identifier: 0315689), 2025.

doi DEA

Journal metrics:

Q1 Multidisciplinary (2024)

Ulambayar, B., Ghanem, A. S., Tóth, Á., Nagy, A. C.: Impact of Physical Activity and Dietary Habits on Mental Well-Being in Patients with Diabetes Mellitus.
Nutrients. 17 (6), 1-12, (article identifier: 1042), 2025.

doi DEA WoS

Journal metrics:

D1 Food Science (2024)

D1 Nutrition and Dietetics (2024)

Ghanem, A. S., Sipos, K., Tóth, Á., Nagy, A. C.: Inflammatory Biomarkers and Oral Health Disorders as Predictors of Head and Neck Cancer: a Retrospective Longitudinal Study.
Int. J. Mol. Sci. 26 (5), 1-20, (article identifier: 2279), 2025.

doi DEA

Journal metrics:

Q2 Catalysis (2024)

Q1 Computer Science Applications (2024)

Q1 Inorganic Chemistry (2024)

Q1 Medicine (miscellaneous) (2024)

Q2 Molecular Biology (2024)

D1 Organic Chemistry (2024)

Q1 Physical and Theoretical Chemistry (2024)

D1 Spectroscopy (2024)

Ghanem, A. S., Tóth, Á., Nagy, A. C.: Socio-demographic disparities in global trends of lip and oral cavity neoplasms from 1990 to 2021.
Sci Rep. 15 (1), 126-131, 2025.

doi DEA

Journal metrics:

Q1 Multidisciplinary (2024)

2024

Tran, A. T., Ghanem, A. S., Móré, M., Nagy, A. C., Tóth, Á.: Efficacy of Prophylactic Antibiotics in COPD: a Systematic Review.
Antibiotics-Basel. 13 (12), 1-16, (article identifier: 1110), 2024.

doi DEA

Journal metrics:

Q1 Biochemistry

Q1 Infectious Diseases

Q2 Microbiology

Q1 Microbiology (medical)

Q1 Pharmacology (medical)

D1 Pharmacology, Toxicology and Pharmaceutics (miscellaneous)

Nagy, A. C., Tóth, Á., Bak, N., Ulambayar, B., Ghanem, A. S., Sztanek, F.: Protective Influence of SGLT-2 Inhibitors Against Heart Failure in Type 2 Diabetes Mellitus Through Longitudinal Clinical Database Analysis.
J. Clin. Med. 13 (23), 1-11, (article identifier: 7093), 2024.

doi DEA

Journal metrics:

Q1 Medicine (miscellaneous)

2022

Mészáros, B., Csóti, Á., Szántó, G. T., Telek, A., Kovács, K., Tóth, Á., Volkó, J., Panyi, G.: The hEag1 K+ Channel Inhibitor Astemizole Stimulates Ca2+ Deposition in SaOS-2 and MG-63 Osteosarcoma Cultures.
Int. J. Mol. Sci. 23 (18), 1-19, (article identifier: 10533), 2022.

doi DEA WoS Scopus

Journal metrics:

Q2 Catalysis

Q1 Computer Science Applications

D1 Inorganic Chemistry

Q1 Medicine (miscellaneous)

Q2 Molecular Biology

Q1 Organic Chemistry

Q1 Physical and Theoretical Chemistry

D1 Spectroscopy

2020

Papp, F., Hajdu, P., Tajti, G., Tóth, Á., Nagy, É., Fazekas, Z., Kovács, S., Vámosi, G., Varga, Z., Panyi, G.: Periodic Membrane Potential and Ca2+ Oscillations in T Cells Forming an Immune Synapse.
Int. J. Mol. Sci. 21 (5), 1-19, 2020.

doi DEA WoS Scopus

Journal metrics:

Q2 Catalysis

D1 Computer Science Applications

D1 Inorganic Chemistry

Q1 Medicine (miscellaneous)

Q2 Molecular Biology

D1 Organic Chemistry

D1 Physical and Theoretical Chemistry

D1 Spectroscopy

2014

Bartók, Á., Tóth, Á., Somodi, S., Szántó, G. T., Hajdu, P., Panyi, G., Varga, Z.: Margatoxin is a non-selective inhibitor of human Kv1.3 K+ channels.
Toxicon. 87, 6-16, 2014.

doi DEA

Journal metrics:

Q2 Toxicology

10.

Szalóki, G., Krasznai, Z. T., Tóth, Á., Vízkeleti, L., Szöllősi, A. G., Trencsényi, G., Lajtos, I., Juhász, I., Krasznai, Z., Márián, T., Balázs, M., Szabó, G., Goda, K.: The strong in vivo anti-tumor effect of the UIC2 monoclonal antibody is the combined result of Pgp inhibition and antibody dependent cell-mediated cytotoxicity.
PloS ONE. 9 (9), 1-9, 2014.

doi DEA

Journal metrics:

D1 Agricultural and Biological Sciences (miscellaneous)

Q1 Biochemistry, Genetics and Molecular Biology (miscellaneous)

D1 Medicine (miscellaneous)

2010

11.

Hajdu, P., Szilágyi, O., Tóth, Á., Krasznai, Z., Pocsai, K., Panyi, G.: Answer to the "comment on functional consequences of Kv1.3 ion channel rearrangement into the immunological synapse" by Stefan Bittner et al. [Immunol. Lett. 125 (Aug 15 (2)) (2009) 156-157].
Immunol. Lett. 129 (1), 47-49, 2010.

doi DEA

Journal metrics:

Q2 Immunology

Q1 Immunology and Allergy

12.

Krasznai, Z. T., Tóth, Á., Mikecz, P., Fodor, Z., Szabó, G., Galuska, L., Hernádi, Z., Goda, K.: Pgp inhibition by UIC2 antibody can be followed in vitro by using tumor-diagnostic radiotracers, 99mTc-MIBI and 18FDG.
Eur. J. Pharm. Sci. 41 (5), 665-669, 2010.

doi DEA

Journal metrics:

Q1 Pharmaceutical Science

2009

13.

Mikecz, P., Márián, T., Miklovicz, T., Galuska, L., Krasznai, Z., Tóth, Á., Goda, K., Trón, L., Hernádi, Z., Krasznai, Z. T.: Daunorubicin and doxorubicin inhibit the [(11)C]choline accumulation in cancer cells.
Appl. Radiat. Isot. 67 (10), 1806-1811, 2009.

doi DEA

Journal metrics:

Q2 Radiation

14.

Mikecz, P., Márián, T., Miklovicz, T., Galuska, L., Krasznai, Z., Tóth, Á., Goda, K., Trón, L., Hernádi, Z., Krasznai, Z. T.: Effect of anthracycline derivatives on the [11C]choline and [18f]FDG accumulation in cancer cells.
Nucl. Med. Rev. Cent. East. Eur. 12 (1), 2009.

DEA

15.

Tóth, Á., Szilágyi, O., Krasznai, Z., Panyi, G., Hajdu, P.: Functional consequences of Kv1.3 ion channel rearrangement into the immunological synapse.
Immunol. Lett. 125 (1), 15-21, 2009.

doi DEA

Journal metrics:

Q2 Immunology

Q1 Immunology and Allergy

16.

Varga, Z., Csépány, T., Papp, F., Fábián, Á. I., Gogolák, P., Tóth, Á., Panyi, G.: Potassium channel expression in human CD4(+) regulatory and naive T cells from healthy subjects and multiple sclerosis patients.
Immunol. Lett. 124 (2), 95-101, 2009.

doi DEA

Journal metrics:

Q2 Immunology

Q1 Immunology and Allergy